The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers.
 
Boris Sepesi
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Speakers' Bureau - AstraZeneca
 
David Randolph Jones
Consulting or Advisory Role - AstraZeneca; Merck
 
Bryan F. Meyers
Consulting or Advisory Role - Armada Health Care
Research Funding - Intuitive Surgical (Inst)
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Flame Biosciences; Genentech/Roche; Guardant Health; Janssen Oncology; Merck; Novartis; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Lynette M. Sholl
Stock and Other Ownership Interests - Moderna Therapeutics (I)
Consulting or Advisory Role - Genentech (Inst); Lilly (Inst)
Research Funding - Roche/Genentech (Inst)
 
Yu Shyr
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Janssen Research & Development; Novartis; Pfizer; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Royalty for TNBCType for Insight Genetics. TNBCType is a web-based subtyping tool TNBCtype for candidate TNBC samples using our gene expression meta data and classification method.
 
Karen Kelly
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Daiichi Sanko; Debiopharm Group; Eisai; EMD Serono; Genentech; Genmab; Janssen; Lilly; Novartis; Regeneron; Sanofi; Takeda; Targeted Oncology
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Meyers Squibb (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - EMD Serono; Lilly; Novartis; Takeda
 
Jules Lin
Honoraria - Intuitive Surgical (Inst)
Consulting or Advisory Role - Lung Bioengineering
Research Funding - Genentech (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Intuitive Surgical
 
Paul A. Bunn
Leadership - Verastem
Honoraria - Ascentage Pharma; AstraZeneca; CStone Pharmaceuticals; Imedex; Ipsen; Lilly/ImClone; Viecure
Consulting or Advisory Role - Ascentage Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; CStone Pharmaceuticals; Genentech/Roche; Imedex; Imedex; Merck; viecure
Travel, Accommodations, Expenses - Verastem
 
John D. Minna
Stock and Other Ownership Interests - Johnson & Johnson; Moderna Therapeutics; Novavax; Qiagen
Research Funding - Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - NIH/NCI (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)
 
Valerie W. Rusch
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Intuitive Surgical
Other Relationship - NIH/Coordinating Center for Clinical Trials
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Asuragen; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Lilly; Flame Biosciences; Flame Biosciences; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Merck; MSD Oncology; Novartis; OncoCyte; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Merck; MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Adaptive Biotechnologies (Inst); Akoya Biosciences (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Iovance Biotherapeutics (Inst); Johnson & Johnson (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Takeda (Inst)
 
David J. Kwiatkowski
Consulting or Advisory Role - AADI; Genentech/Roche
Research Funding - AADi; Genentech/Roche; Revolution Medicines
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb Japan; Daiichi Sankyo; Eisai; EMD Serono; Flame Biosciences; Genentech/Roche; Geneplus; GlaxoSmithKline; Gritstone Bio; Intellisphere; Janssen; Johnson & Johnson/Janssen; Lilly; Merck; Mirati Therapeutics; Novocure; OncoCyte; Oncohost; Regeneron; Roche China; Sanofi; Seagen
Research Funding - Bristol-Myers Squibb
 
Lynne D. Berry
No Relationships to Disclose
 
Jay M. Lee
Stock and Other Ownership Interests - Moderna Therapeutics
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Genentech/Roche; Novartis
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Novartis
 
Khaled Tolba
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Foundation Medicine
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer
Travel, Accommodations, Expenses - Genentech